Stay Ahead with the Latest Oncology Insights

Breaking news and expert analysis for today’s oncology professionals

Conferences

5 Updates From ESMO 2025 for Lung Cancer Oncologists

Rami Manochakian, MD, of Mayo Clinic, joins the Oncology Brothers podcast to review data from the MDT-Bridge, FLAURA2, NorthStar, SOHO-01, and Beamion LUNG 1 trials presented at the ESMO Congress 2025.

Rami Manochakian, MD, Rohit Gosain, MD, Rahul Gosain, MD, MBA

See More

5 Updates From ESMO 2025 for Lung Cancer Oncologists

ESMO 2025 Updates in Prostate Cancer: Advances in Radioligand, Genomic, and AR-Targeted Therapies

Conferences

ESMO 2025 Updates in Prostate Cancer: Advances in Radioligand, Genomic, and AR-Targeted Therapies

Michael Serzan, MD

Metastatic Breast Cancer Updates: SERDs, mTOR Inhibitors, and VIKTORIA-1

Conferences

Metastatic Breast Cancer Updates: SERDs, mTOR Inhibitors, and VIKTORIA-1

Erika Hamilton, MD, FASCO, Sarah Premji, MD

5 Key GI Cancer Updates From ESMO 2025

Conferences

5 Key GI Cancer Updates From ESMO 2025

Rachna Shroff, MD, MS, FASCO, Rohit Gosain, MD, Rahul Gosain, MD, MBA

8 Practice-Changing Breast Cancer Presentations From ESMO 2025

Conferences

8 Practice-Changing Breast Cancer Presentations From ESMO 2025

Virginia Kaklamani, MD, DSc, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Dr. Erika Hamilton on Updated Results From monarchE Presented at ESMO 2025

Conferences

Dr. Erika Hamilton on Updated Results From monarchE Presented at ESMO 2025

Erika Hamilton, MD, FASCO, Sarah Premji, MD

Top 5 GU Oncology Presentations From ESMO Congress 2025

Conferences

Top 5 GU Oncology Presentations From ESMO Congress 2025

Stephanie Berg, DO, Rahul Gosain, MD, MBA, Rohit Gosain, MD

ESMO 2025: Updates in Bladder Cancer

Conferences

ESMO 2025: Updates in Bladder Cancer

Vishesh Khanna, MD

ESMO 2025 Breaking New Ground in Breast Cancer: Five Trials to Know

Conferences

ESMO 2025 Breaking New Ground in Breast Cancer: Five Trials to Know

Matthew Kurian, MD

Upcoming Events

Dec 7, 2025

Advancements in Oncology: Orlando

Join the Oncology Brothers and leading experts live in Orlando! Explore how new data from ASH 2025 will impact clinical practice. Enjoy a networking reception followed by expert-led panels on Multiple Myeloma, Lymphoma, CLL, and Leukemia cancer subtypes.

OncUpdates live event poster for oncology advancements, breast cancer research, HER2+ therapy, TNBC, and HR+ subtypes, featuring top oncology experts in San Antonio, with event details and expert panelists.

Dec 10, 2025

Advancements in Oncology: San Antonio

Join the Oncology Brothers and leading experts live in San Antonio for an exclusive event exploring how new data from SABCS 2025 will impact clinical practice. Enjoy a networking reception followed by expert-led panels on HR+, HER2+, and TNBC breast cancer subtypes.

CONFERENCES

Browse All CONFERENCES

Lung Cancer

5 Updates From ESMO 2025 for Lung Cancer Oncologists

Rami Manochakian, MD | Rohit Gosain, MD | Rahul Gosain, MD, MBA

Breast Cancer

Metastatic Breast Cancer Updates: SERDs, mTOR Inhibitors, and VIKTORIA-1

Erika Hamilton, MD, FASCO | Sarah Premji, MD

GI Oncology

5 Key GI Cancer Updates From ESMO 2025

Rachna Shroff, MD, MS, FASCO | Rohit Gosain, MD | Rahul Gosain, MD, MBA

8 Practice-Changing Breast Cancer Presentations From ESMO 2025 with leading doctors Dr. Rahul Gosain, Dr. Rohit Gosain, and Dr. Virginia Kaklamani; innovative updates in breast cancer diagnosis, treatment, and care discussed at OncUpdates.

Breast Cancer

8 Practice-Changing Breast Cancer Presentations From ESMO 2025

Virginia Kaklamani, MD, DSc | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Tox Check

Browse All TOX CHECK

Breast Cancer

Managing Side Effects of CDK4/6 Inhibitors in Breast Cancer

Stephanie Graff, MD, FACP, FASCO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Strategies to Minimize Side Effects in RCC Treatment for Oncology Professionals - OncUpdates.

Videos & Podcasts

Strategies to Minimize Side Effects in RCC Treatment

Sumanta Pal, MD, FASCO | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Managing side effects of anti-VEGF Bevacizumab and anti-EGFR Cetuximab and Panitumumab in cancer treatment, presented by OncUpdates.

Videos & Podcasts

Managing Side Effects of Panitumumab, Cetuximab, and Bevacizumab

Pashtoon Kasi, MD, MS

Managing side effects of pancreatic cancer treatment with expert insights from oncologists and latest research updates on ToxCheck.

Videos & Podcasts

Managing Toxicities of FOLFIRINOX and Nab-Paclitaxel Plus Gemcitabine

Midhun Malla, MD | Rachna Shroff, MD, MS, FASCO

NEW APPROVALS

Browse All New Approvals

FDA approval of Zongertinib in HER2-mutated NSCLC for targeted cancer treatment.

Videos & Podcasts

FDA Approval of Zongertinib in HER2-Mutated NSCLC

Joshua Sabari, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

FDA approves Dato-DXd for EGFR-mutated NSCLC patients - latest oncology update from OncUpdates.

Videos & Podcasts

FDA Approves Dato-DXd for Patients With EGFR-Mutated NSCLC

Jacob Sands, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Videos & Podcasts

FDA Approval of Cabozantinib in Neuroendocrine Tumors

Aman Chauhan, MD

Perioperative Durvalumab FDA approval for muscle invasive bladder cancer, OncUpdates news.

Videos & Podcasts

Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer

Thomas Powles, MD, MBBS, MRCP

TREATMENT ALGORITHMS

Browse All TREATMENT ALGORITHMS

Ovarian Cancer

Unraveling the Treatment Algorithm for Ovarian Cancer

Sharyn N. Lewin, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Dr. Jorge Cortes

Videos & Podcasts

Treating CML in 2025: TKIs and Transplant

Jorge Cortes, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

OncUpdates theme focusing on colorectal cancer treatment and oncology advancements, featuring oncologists Dr. Rohit Gosain, Dr. Rahul Gosain, and Dr. Mazyar Shadman for community oncology education.

Videos & Podcasts

CLL Treatment Landscape for the Community Oncologist

Mazyar Shadman, MD, MPH | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Myelofibrosis treatment algorithm 2025, oncological updates by Dr. Raajit Rampal and experts in hematology and cancer research.

Videos & Podcasts

Myelofibrosis Treatment Algorithm in 2025

Raajit Rampal, MD, PhD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

CHALLENGING CASES

Browse All CHALLENGING CASES

Eric Singhi

Lung Cancer

Treating Complex Cases of EGFR-Mutated NSCLC

Eric Singhi, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Overcoming challenges in relapsed or refractory FLT3-positive AML featuring Dr. Uma Borate, Dr. Navali Daver, Dr. Rohit Gosain, and Dr. Rahul Gosain, discussing innovative approaches in hematology and oncology.

Videos & Podcasts

Overcoming Challenges in Relapsed or Refractory FLT3-Positive AML

Naval Daver, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD | Uma Borate, MBBS

Bioscientists discussing targeted bispecific antibody therapies in relapsed/refractory diffuse large B-cell lymphoma (DLBCL) at OncUpdates conference.

Videos & Podcasts

Selecting Bispecific Antibody Therapies in RR DLBCL

Carla Casulo, MD | Tara Graff, DO, MS

CLINICAL INSIGHTS

Browse All CLINICAL INSIGHTS

In-depth analysis of key insights from IMforTe regarding treating ES-SCLC with expert clinicians Dr. Stephen Liu, Dr. Ticiana Leal, Dr. Isabel Preeshagul, Dr. Rohit Gosain, and Dr. Rahul Gosain.

SCLC

Key Takeaways From IMforte for Clinicians Treating ES-SCLC

Ticiana Leal, MD | Stephen Liu, MD | Isabel Preeshagul, DO, MBS | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Sequencing Lurbinectedin in ES-SCLC with CNS Involvement - OncUpdates featuring Dr. Stephen Liu, Dr. Ticiana Leal, Dr. Rahul Gosain, and Dr. Rohit Gosain focusing on recent advancements in small cell lung cancer treatment.

SCLC

Sequencing Lurbinectedin in ES-SCLC with CNS Involvement

Ticiana Leal, MD | Stephen Liu, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Lurinctedin adverse events management in ES-SCLC maintenance therapy with expert doctors Dr. Rohit Gosain, Dr. Rahul Gosain, Dr. Isabel Preeshagul, and Dr. Stephen Liu, from OncUpdates.

SCLC

Managing Lurbinectedin Adverse Events in ES-SCLC Maintenance Therapy

Isabel Preeshagul, DO, MBS | Stephen Liu, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD

Immunotherapy and clinical research experts discussing the clinical relevance of IMforTE survival data in ES-SCLC. Featuring Dr. Ticiana Leal, Dr. Stephen Liu, Dr. Rahul Gosain, and Dr. Rohit Gosain at OncUpdates.

SCLC

Clinical Relevance of IMforte Survival Data in ES-SCLC

Ticiana Leal, MD | Stephen Liu, MD | Rahul Gosain, MD, MBA | Rohit Gosain, MD